O
ORUKA THERAPEUTICS, INC.
NASDAQ: ORKA (Oruka Therapeutics, Inc.)
Last update: 9 hours ago102.86
6.84 (7.12%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Oruka Therapeutics, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 0.0 |
| Price Volatility | -1.8 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Relative Valuation | NA |
| Financial Health | 1.7 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | 0.27 |
Select this tab to load the latest available analysis.
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.82% |
| % Held by Institutions | 86.62% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Paradigm Biocapital Advisors Lp | 30 Jun 2026 | 2,144,526 |
| Remedium Capital Partners, Llc | 30 Jun 2026 | 1,565,661 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| KLEIN LAWRENCE OTTO | - | 95.43 | -25,000 | -2,385,750 |
| Aggregate Net Quantity | -25,000 | |||
| Aggregate Net Value ($) | -2,385,750 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 95.43 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KLEIN LAWRENCE OTTO | Officer | 02 Nov 2026 | Automatic sell (-) | 25,000 | 95.43 | 2,385,750 |
| KLEIN LAWRENCE OTTO | Officer | 02 Nov 2026 | Option execute | 25,000 | - | - |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |